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multiple logistic regression.  Conclusion: The significance of 
VC or CDAI for predicting the extent of surgery or complica-
tions is limited. None of the tested variables except preop-
erative nicotine abuse influenced the likelihood for periop-
erative complications.  Copyright © 2006 S. Karger AG, Basel 
 Introduction 
 More than two thirds of patients with Crohn’s disease 
(CD) require surgery during their lifetime  [1] . This situ-
ation is made more serious by an increased risk for peri-
operative complications and re-operations among these 
patients when compared to a general patient population. 
For this reason, a preoperative score, which would allow 
the prediction of the extent of surgery required, the peri-
operative risk, and the likelihood of disease recurrence 
would be extremely valuable  [2] .
 Quantification and scoring systems, such as the CD ac-
tivity index (CDAI) of Best and the Vienna classification 
(VC)  [3–5] ( fig. 1 ) have been introduced. These are intend-
ed for the estimation of CD severity in clinical practice, 
mainly for evaluation of conservative, medical treatment 
 [3, 6–8] . Whereas the VC aims to identify patient sub-
groups with increased risk factors, such as age at disease 
onset (A), location (L) and behavior characteristics (B)  [5, 
9] , the CDAI is a calculated index, combining patients vital 
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 Abstract 
 Background: Crohn’s disease (CD) patients with increased 
disease activity may reveal an increased risk for periopera-
tive complications. The ‘Crohn’s disease activity index’ (CDAI) 
and the ‘Vienna classification’ (VC) were developed for stan-
dardized disease activity estimations. The significance of 
these scores to predict extent, type and early outcome of 
surgery in CD patients was analyzed.  Methods: In 179 surgi-
cally treated CD patients, the CDAI and VC were assessed 
from a prospective database. Relations of the scores with CD 
risk factors, type, number, location and complications of sur-
gery were analyzed.  Results: VC behavior and location sub-
types were associated with distinct types of surgery (i.e.
‘strictureplasty’ in ‘stricturing disease’, ‘colon surgery’ in
‘colon involvement’), but not with surgery type and extent 
or outcome. Surgery extent (i.e. with 5 vs. 3 ‘surgical sites’ 
425  8 25 vs. 223.3  8 25) and complications (357.1  8 36.9 
(with) vs. 244.4  8 13 (without)) were associated with elevat-
ed CDAI levels; however, nicotine abuse remained the only 
significant risk factor for perioperative complications after 
 Received: April 21, 2006 
 Accepted: July 6, 2006 
 Published online: August 28, 2006 
 Markus Rentsch, MD
Department of Surgery, Klinikum Grosshadern
Ludwig-Maximilians University of Munich, Marchioninistrasse 15
DE–81377 Munich (Germany)
Tel. +49 89 7095 2790, Fax +49 89 7095 5655, E-Mail mrentsch@med.uni-muenchen.de 
 © 2006 S. Karger AG, Basel
0253–4886/06/0234–0241$23.50/0 
 Accessible online at:
www.karger.com/dsu 
M. Rentsch and A. Beham contributed equally to this work.
 Rentsch  /Beham  /Schlitt  /Jauch  
 
Dig Surg 2006;23:241–249242
parameters (i.e. temperature, body weight, white blood cell 
count), clinical findings (abscess/fistula, abdominal mass, 
body weight/temperature) and medical history (extrain-
testinal symptoms), reflecting general disease activity. It 
may be misleading to apply these two indices to decision 
making involving patient’s awaiting surgery. In the pre-
operative environment, clinical parameters may be altered 
by previous drug treatment  [10–12] , changes in the disease 
pattern may occur  [9] , and diagnostic findings may under-
estimate the true extent of the disease  [13] . Therefore, the 
aim of the present study is to analyze the accuracy of both 
scores in predicting the intra-operative extent of the dis-
ease, the amount and technique of surgical therapy re-
quired, and early postoperative outcome.
 Methods 
 The study population consisted of patients referred for surgi-
cal treatment to the Department of surgery at the University of 
Regensburg and registered in a prospective database. Measures of 
disease activity and extent, verified pre-operatively and during 
surgery, were analyzed retrospectively. All surgeries and intra-
operative assessments were performed by ten experienced sur-
geons.
 Subgroups were categorized according to age, disease location 
and behavior (structuring, perforating or the combination of 
both). General patient characteristics, including family history, 
general clinical status, medical history (current medication) and 
preoperative findings, as well as surgical interventions, and im-
mediate surgical outcomes (perioperative complications) were re-
corded ( table 1 ). Nicotine abuse was defined as any nicotine abuse 
at the time of surgery.
 Diagnostic Techniques 
 Leading diagnoses were ascertained instantly before surgery 
with one or a combination of common diagnostic techniques 
[range 1–8, median 3 diagnostic techniques], depending on the 
certainty of the results. Definite diagnoses were obtained with 
ultrasound (57%), endoscopy (56%), intestinal contrast X-ray 
(50%), computed tomography (33%), abdominal X-ray examina-
tion (20%), barium enema (10.6%), and magnetic resonance im-
aging (9%).
 Analyses were focused on the determination of the CDAI and 
the VC. We did depart from the original VC in one instance: pa-
tients were classified regardless of  first  or  recurrent  surgery for CD 
at the time of admission in our unit. Patients without surgical 
treatment and patients with non-Crohn-related diseases under-
going surgery were excluded from statistical analyses.
 Only patients with complete prospectively determined CDAI 
were considered for analyses. Since the prospective CDAI docu-
mentation was incomplete in 50 patients (i.e. patients with exclu-
sively perianal disease), data on VC (174 patients), and CDAI (124 
patients) were separately calculated.
 Fig. 1. Overview of both analyzed CD scoring systems. Whereas the CDAI represents clinical and subjective 
patient data reflecting the disease activity, the VC theoretically would allow conclusions on disease activity by 
identifying risk groups according to their macroscopic disease appearance (stricturing, perforating, and in-
volvement of the upper GI tract). 
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 Statistical Analyses 
 Descriptive and univariate analyses were performed to sum-
marize the data. Categorical variables were compared between 
subgroups with the    2  or Fisher’s exact test. Correlations among 
variables were assessed by calculation of the Spearman coeffi-
cient. CDAI values were tested for presence of normal distribution 
and compared with the Student t test or one-way ANOVA.
 In a second step, variables were re-evaluated by general multi-
factorial analysis of variances and stepwise logistic regression. 
p  ! 0.05 was considered significant. Analyses were carried out 
with SPSS statistical software, version 13.0 (SPSS  Inc., Chica-
go, Ill., USA).
 Results 
 General Patient Characteristics 
 One hundred and ninety-eight patients with the diag-
nosis of CD were treated in our department between June 
1992 and July 2000. The demographic data are summa-
rized in  table 2 . 39% of the patients had surgery elsewhere 
previous to admission, 17% had undergone intestinal re-
section. No patients were submitted for secondary surgi-
cal treatment of postoperative complications.
Table 1. Registered data within the patient population
Patient history and
diagnostic procedures
Preoperative
assessment
Intra-/postoperative
assessment 
General data CDAI emergency surgery
Age elective surgery
Onset of disease repeat surgery
Gender resection/strictureplasty
Disease-specific risk factors VC surgery location
Nicotine abuse stomach
NSAID duodenum
Oral contraceptives jejunum
Mycobacteria tuberculosis ileum
Immunization to measles ileocecum
ascendending colon
transverse colon
Diagnostic procedures disease localizaton descending colon
Ultrasound esophageus/stomach rectosigmoid colon
X-ray abdomen duodenum/jejunum
Small bowel enema ileum preexisting anastomosis
Colonography ileocecum
CT scan ascending colon fistula drainage
MRI  transverse colon seton placement
Biopsy descending colon advancement flap
rectosigmoid colon
perianal disease abscess drainage
pre-existing complications perioperative complications
stenosis anastomotic leakage
ileus peritonitis
abscess sepsis
(intra-/extra-abdominal) wound infection/
fistulae dehiscence
entero-enteral infection (other)
entero-cutaneous hemorrhage
entero-vesical bowel obstruction
entero-genital early recurrence
other abscess
hemorrhage fistula
malignancy thrombembolic event death
Note that 170 patients have been analyzed after exclusion of surgical procedures without relation to CD and 
in 124 patients CDAI data were obtained for statistical evaluation.
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 Surgical procedures are listed in detail in  table 3 . In 5 
patients, laparotomy was indicated due to causes unre-
lated to CD. Specifically, indications were (a) mechani-
cal bowel obstruction after prior surgery (3 patients); 
(b) cholecystitis (1 patient), and (c) an incarcerated inci-
sional hernia (1 patient). These patients were excluded 
from further analysis. 65 patients presented as emergen-
cies (GI bleeding: 3 patients, Crohn-related mechanical 
obstruction: 12 patients, intra- or extra-abdominal ab-
scesses: 22 and 28 patients, respectively), 11 of whom 
required acute surgical therapy. Resections were per-
formed in 138 patients, vs. 15 patients with strictureplas-
ties (two strictureplasties in 2 patients, five in 1 patient; 
 table 3 ).
 Medical Therapy 
 Medical therapy prior to surgery included corticoste-
roids in 59.2% of the patients, 5-ASA in 44.3%, azathio-
prine in 9.8%. No patient received 6-mercaptopurine or 
anti-TNF-  treatment. 6.3% were treated with ciproflox-
acin and 9.8% with metronidazole. There were no differ-
ences in the CDAI scores of patient groups treated with 
different medical therapies.
 Of note, corticosteroid medication was used in 77% of 
the patients with disease location proximal to the ileum 
(vs. 55% under corticosteroid therapy overall, p = 0.03, 
   2 ) and in 71.4% of the patients with stricturing disease 
behavior (vs. 53.4% patients without strictures, p = 0.02; 
   2  and logistic regression). In contrast, patients without 
CD proximal to the ileum more frequently received aza-
thioprine (22 vs. 7.4% overall, p = 0.018,    2 ). Ciprofloxa-
cin (9.5%) and metronidazole (14%) were predominately 
used in patients with intra-abdominal abscess formation 
(p  ! 0.006;    2  and logistic regression).
Patients admitted, total 198
Surgery/medical management 177 (88.9%)/21 (11.1%)
Gender, men:women 80:97
Age at surgery, years median, min/max M: 32,5; 14/61
W: 34,0; 16/70
Age at first diagnosis, years median, min/max M: 25,0; 11/60
W: 25,0; 8/57
Repeat surgery 69 (39.7%)
Emergency 11 (6.4%)
Medication before surgery, steroids 103 (59.2%)
patients azathioprin 17 (9.8%)
5-ASA 77 (44.3%)
anti-TNF 0
ciprofloxacin 11 (6.3%)
metronidazole 17 (9.8%)
combined drug therapy 79 (45.4%)
Table 2. General patient characteristics
Table 3. Characterization of surgical procedures and surgical site 
(multiplicity of sites included)
Patients/percentages
Emergency surgery 11/6.4
Elective surgery 160/93.6
Repeat surgery 67/39
Resection:strictureplasty 151/82.5:15/8.8
Stoma (ileostoma) 8/4.7
Fistula drainage 13/7.6
Seton placement 13/7.6
Advancement flap 2/1.2
Abscess drainage 22/12.9
Surgical site
Stomach 0
Duodenum 2/1.2
Jejunum/ileum 23/13.5
Ileocecum 91/53.2
Ascendending colon 19/11.1
Transverse colon 17/9.9
Descending colon 9/5.3
Recto-sigmoid 27/15.8
Preexisting anastomosis 13/7.6
 Significance of CDAI and Vienna 
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 Age/Gender 
 The median age of our study group (95 women and 79 
men) at the time of surgery was 34.0 years (17–62) and 
31.5 years (17–58), respectively. 27.6% were older than 40 
years and 9.2% younger than 20 years. At primary diag-
nosis, 14.9% of the patients were older than 40 years. 
CDAI levels were equal in both age groups (see  table 5 ). 
In addition, no significant relation between age ( ! / 6 40 
years, classification parameter A) and  preoperative dis-
ease location (classification parameter L) was detectable. 
Nevertheless, higher age was associated with an elevated 
ratio of patients with stricturing  disease (50 vs. 25.4%, 
p = 0.002; Spearman correlation 0.235). Gender had no 
impact on the investigated parameters.
 Location of Disease 
 Location 1 (ileum plus spillover to cecum) was diag-
nosed in the majority of the patients (n = 139). This num-
ber includes patients who had a previous ileocecal resec-
tion. All 97 patients, who presented with colon involve-
ment, had a diseased terminal ileum (L3). CD spreading 
proximal to the ileum was detectable in 27 patients. In all 
regions, the primarily diagnosed disease location re-
vealed a significant relation with the surgically treated 
locations (p  ! 0.0001;  table 4 ). This was reconfirmed by 
stepwise logistic regression. However, the Spearman co-
efficients revealed weak positive correlations between 
pre- and intraoperatively determined locations ( table 4 ).
 Stratification of the patients into the four VC disease 
location subgroups revealed no differences in CDAI. How-
ever, multiplicity of disease locations was accompanied by 
a high CDAI variation. CDAI levels ranged between 223.3 
 8 25.4 and 425.0  8 24.8 for subgroups with 1–5 or more 
sites of surgery and a significantly higher CDAI was asso-
ciated with 5 vs. 3 locations (p = 0.07,    2 ). Since certain 
patient subgroups obviously required a different intensity 
of medical treatment, we hypothesized that the CDAI may 
vary in VC subgroups. However, no differences in CDAI 
values were observed in the VC location subgroups.
 Behavior of Disease 
 56 patients presented with stricturing vs. 105 patients 
with penetrating disease behavior. 37 patients showed 
neither strictures nor penetrations. However, 24 patients 
had combinations of strictures and penetrations, and 
were, therefore, not represented by the VC. As expected, 
significantly (p  ! 0.001) more strictureplasties were per-
formed in patients with stricturing disease behavior and 
with involvement of the upper gastrointestinal tract (vs. 
other bowel regions) ( table 4 ). Interestingly, stratification 
according to behavior factors (3) revealed an elevated 
CDAI (463  8 21,  table 5 ) in patients with the simultane-
Vienna
classification factor
Presence Surgical intervention
yes/no
 2 Spearman
correlation
Location 1 yes 138 yes 117 <0.0001 0.491
no 36 no 57
2 yes 98 yes 45 <0.0001 0.416
no 76 no 129
3 yes 97 yes 127 0.206 –0.096
no 77 no 47
4 yes 27 yes 27 <0.0001 0.431
no 147 no 148
Behavior 1 yes 38 yes 100a 0.005 0.231
no 136 no 74
2 yes 138 yes 138 0.002 0.277
no 36 no 36
3 yes 106 yes 67b <0.0001 0.620
no 68 no 107
X yes 137 yes 67b <0.0001 0.529
no 37 no 107
a Surgical interventions without fistula excision or abscess drainage.
b Exclusively surgical interventions with fistula excision or abscess drainage.
X  = Combined structuring and perforating disease behaviour, not classifiable in 
VC.
Table 4. Relation between preoperative 
and intraoperative findings according to 
the VC as assessed by 2 test and 
Spearman correlation
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ous presence of three or more different fistulae (i.e. en-
terocutaneous plus enteroenteral plus enterovaginal), 
however without significance in comparison to patients 
with less than three fistulae.
 Extent of Surgery 
 101 patients (58%) revealed a multifocal disease pat-
tern (2–6 locations) that could not be represented by a 
precise VC categorization. 
 When the CDAI was analyzed according to the extent 
of surgical therapy, only the necessity of surgery at more 
five or more vs. three locations (resection and stricture-
plasty) was associated with a markedly higher score ( ta-
ble 5 ).
 Perioperative Complications  
 No lethal complications were noted. Perioperative 
complications ( table 6 ) occurred in 10.5% of the patients, 
with 4.1% displaying anastomotic leakage. Three patients 
Clinical situation Status CDAI p value
Age <40 years yes 242814 0.29
no 279828
VC location 4 yes 263841 0.91
no 249813
VC behavior 3 yes 256818 0.79
no 243817
Ileus yes 271851 0.67
no 249813
Presence of fistulas yes 255819 0.89
no 246816
Multiple independent yes 1 system 253821
fistula systems 2 systems 227852
3 or more s. 463821 0.128
no 246816
Extraintestinal yes 1 location 255829
manifestation 2 locations 3938110 0.293
no 244813
Surgery upper GI tract yes 280835 0.32
no 245813
Surgery colon yes 1 site 277833 0.125
2 345850
3 or more 369875
no 229814
Surgery multiple sites yes 1 246818
2 261830 0.07 (5 vs. 1 
3 223825 site) and 0.04
4 241851 (5 vs. 3 sites)
5 or more 425825
no 212 (2 pat.)
Emergency yes 207843 0.431
no 253813
CDAI given as mean 8 SEM, p values calculated by use of Student’s t test or one-way 
ANOVA after rank transformation of non-normally distributed CDAI values. Note that 
none of the factors had any impact on short-term postoperative outcome.
Table 5. CDAI variations in dependence 
of clinical situation
 Significance of CDAI and Vienna 
Classification in Surgery 
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(1.8%) developed a generalized peritonitis. Early fistula 
recurrence appeared in 2 (1.2%) and wound dehiscence 
in 4 (2.4%) patients. Half of the patients with complica-
tions presented with two or more complications at once.
 The average CDAI of patients with complications (over-
all 340.9  8 27.9) and with complications requiring revi-
sion surgery (353.2  8 34.9) was elevated in comparison to 
patients without complications (240.2  8 13.6, p  ! 0.05). 
Analogously, patients with postoperative anastomotic 
leakage revealed significantly elevated CDAI levels (357.1 
 8 36.9 vs. 244.4  8 13.2, p  ! 0.05). However, multivariate 
calculations abolished the significant differences in CDAI 
in patients with or without postoperative complications.
   2  calculations showed significant (p  ! 0.05) associa-
tions of VC behavior types 1, 3, and combined stricturing 
plus perforating disease with later perioperative complica-
tions. Moreover, corticoid medication (p = 0.025), resec-
tion surgery performed at the ileocecal region (p = 0.02), 
combined disease pattern (0.24) and nicotine abuse (p = 
0.003) were significantly associated with anastomotic leak-
age. After stepwise logistic regression, however, nicotine 
abuse remained the only significant variable increasing the 
risk for postoperative anastomotic leakage (p = 0.037) and 
perioperative complications in general (p = 0.004).
 Discussion 
 In the present study we evaluated, the usefulness of the 
‘VC’ and the ‘CDAI’, when applied preoperatively to CD 
patients, in predicting the extent and type of surgery re-
quired and the risk of early surgical complications. Both 
instruments have been predominately applied to patients 
who are treated medically, but not surgically  [3–5] .
 In general, quantification of CD activity may be prob-
lematic, due to the frequently complex disease appear-
ance. Any information about the disease aggression 
would be useful for a multimodal treatment concept in-
cluding medical pretreatment, surgical strategy and post-
operative maintenance therapy, balancing quality of life 
 [14] , requirement of side effect charged drug therapy vs. 
the probability for surgery  [10, 15, 16] , including the risk 
of recurrence and re-operation  [10, 17] . Precise informa-
tion on the surgery-associated risk is of fundamental im-
portance to the patient  [2] .
 The examined classifications are based on different 
types of Crohn’s-associated data, and are therefore not 
comparable. Whereas the CDAI includes numerous sub-
jective and clinical data (vital parameters, body weight, 
abscess/intra-abdominal mass), the VC focuses on mor-
phological characteristics of the disease. Therefore, we 
presumed that by quantificating the CDAI in certain VC 
subgroups we would be most likely to identify patient 
subgroups with increased CDAI, who were particularly 
prone to increased disease extent and perioperative risk.
 Preoperative medical therapy, i.e. corticosteroids, may 
decrease disease activity and subjective complaints, and 
therefore, interfere with the reliability of the VC and the 
CDAI. Bowel strictures and inflammatory changes may 
rapidly resolve  [12, 18] , which may change the pheno-
typic disease appearance  [9] . Since nearly 60% of our pa-
tients received steroids preoperatively, we cannot exclude 
that drug treatment interfered our observations. How-
ever, the diagnostic procedures in our study immediately 
preceded surgery, and the majority of patients with dif-
ferent intra- vs. preoperative disease extent and location 
consistently revealed more diseased locations intraopera-
tively. Furthermore, since corticosteroid therapy had no 
effect on the CDAI in our patients, it is unlikely that cor-
ticosteroids acted as disease-resolving agent and signifi-
cantly affected our results. The evidently low number of 
patients on azathioprine at the time of surgery in our 
study may be explained by our center policy with restric-
tive use of azathioprine (and 6-mercaptopurine) and 
complete avoidance of anti-TNF treatment for remission 
maintenance therapy  [19] .
 Younger, as well as older, age at first diagnosis has been 
identified as risk factor for CD recurrence, reflecting gen-
eral disease activity  [17] . However, numerous large stud-
ies failed to show any influence of age on disease recur-
rence  [16, 20, 21] . In our study, as well, we found no as-
Table 6. Perioperative complications
Complication Number/
percent
Anastomotic leakage 7/4.1
Peritonitis 3/1.8
Sepsis 0/ND
Wound infection/dehiscence 2/1.2
Infection (other) 7/4.0
Hemorrhage 0/ND
Bowel obstruction 0/ND
Early recurrence
Abscess
Fistula 2/1.2
Thrombembolic event 1/0.6
Death 0/ND
Total 22/13.2
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sociations with age and the other VC classification factors, 
or with CDAI levels. Reducing the cut-off value of the VC 
from 40 to 20 years of age, as proposed earlier  [17] , had 
no influence on the findings.
 CD activity may be determined by disease location, 
multiplicity of locations, disease behavior (perforating/
fistulizing), and inflammatory activity  [16, 22–26] . Both, 
the VC and CDAI, would thus theoretically allow a pre-
diction of intraoperative findings. However, our analyses 
revealed no associations between the VC or the CDAI and 
intraoperative findings. Although a larger number of lo-
cations requiring surgical therapy (5 vs. 3), was reflected 
by an elevation of the CDAI, this trend was not linear, 
since no progressive increase in the CDAI was notable 
from 1 to 5 locations. Furthermore, patients displaying 
complex disease patterns with more than two indepen-
dent fistulae revealed higher CDAI levels than those with 
single fistula. However, an aggressive disease type might 
be presumed in patients with CD manifestation in five 
different locations or with complex fistula combinations 
without the use of a special classification.
 Although the analyses of VC categories revealed sig-
nificant associations between pre- and intraoperative lo-
cations, correlations were weak, as indicated by a low 
Spearman coefficient. Moreover, these associations could 
have been expected without special classification. In ad-
dition, a clear allocation into the subgroups of the VC is 
not possible in patients with combined fistulizing and 
stricturing disease, which was present in the vast major-
ity (78%) of patients.
 Furthermore, the extent of CD surgery may be antici-
pated by clinical data included in the CDAI, such as WBC 
count and fever, abdominal mass, and the presence of ab-
scesses/fistulae. We therefore evaluated the CDAI in pa-
tient subgroups, reflecting risk constellations for in-
creased CD aggression  [27, 28] . Although elevated CDAI 
scores ( 1 200) were recognizable in the majority of the 
subgroups, no disease ‘subtype’ except ‘multiple indepen-
dent fistulae’ was associated with significantly elevated 
CDAI values. This finding is not surprising, since ‘subjec-
tive well-being’ is considerably influenced by the pres-
ence of fistulas  [14] . Both ‘subjective well-being’ and the 
presence of abscess/fistulae are heavily weighted factors 
( ! 7 and  ! 20;  fig. 1 ) within the CDAI.
 Surgical therapy prior to the VC and CDAI staging 
may have biased our results, since the specificity of diag-
nostic techniques preoperatively may be altered  [13] , and 
anastomoses may mature into restenoses. However, com-
parison of the CDAI’s of patients with or without preced-
ing surgery showed no statistical difference.
 As mentioned previously, the number of strictures is 
often underestimated by radiographic as compared to 
surgical findings in CD patients  [13] . Peristalsis and wid-
ening as well as distension or adhesions of the intestinal 
tract may mislead the examiner, who may furthermore 
focus on the most dominant lesion, causing him to direct 
less attention towards other findings  [13] . Although in 
our study diagnoses relied on combined techniques in-
cluding endoscopy, radiographic examinations, CT, MRT 
and ultrasound, we frequently (54.4%) found that while 
only a single site was diagnosed preoperatively, more sites 
actually required surgical therapy.
 Since we had found that pre-operative classifications 
did not predict intraoperative disease extent in CD pa-
tients, we sought to determine whether preoperative find-
ings could predict early postoperative complications  [28–
30] . With univariate comparisons, we confirmed that the 
following established risk factors: complex disease pat-
tern, ileocecal resection, corticoid medication and nico-
tine abuse were significantly related to postoperative 
complications. The low overall number of complications 
in our study, however, may lead to underrating of rela-
tions to certain VC subfactors. Slightly elevated CDAI 
levels were observed along with postoperative complica-
tions, infectious complications, anastomotic leakage and 
pre-existing bowel obstruction. This is in agreement with 
the general concept that an exaggerated disease accom-
panies an increased perioperative risk  [27] . In multivari-
ate analyses, nicotine abuse remained the only predictive 
factor associated with an elevated risk for perioperative 
complications and anastomotic leakage, which is in ac-
cordance with the previously observed heightened risk of 
disease recurrence in smokers  [31] .
 Together, the VC and the CDAI may be useful for 
monitoring disease activity under conservative therapy. 
However, they are less useful for surgical therapy plan-
ning and perioperative risk prediction. Nicotine abuse, 
which emerged as the most relevant risk factor for peri-
operative complications, for instance, does not contribute 
to any classification. Indications for surgery should de-
pend on disease extent and activity, on refractoriness to 
medical therapy, and on pre-existing complications, such 
as bowel obstruction, perforation, hemorrhage, abscess 
formation, toxic megacolon and endoscopic proof of 
high-grade dysplasia  [10, 14, 16, 32] .
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